Mesa Laboratories (MLAB) Operating Leases (2026)
Mesa Laboratories' (MLAB) quarterly Operating Leases came in at $15.9 million in Q2 2026, up 16.03% quarter-over-quarter from $13.7 million in Q1 2026.
Powered by 
Analysis
Mesa Laboratories (MLAB) Operating Leases (2026) Analysis & Trends
Mesa Laboratories has disclosed Operating Leases across 1 years of filings, most recently posting $15.9 million for Q2 2026.
- In Q2 2026, Operating Leases changed N/A year-over-year to $15.9 million; the TTM figure through Jun 2026 stood at $15.9 million (changed N/A YoY), while the FY2026 annual figure was $13.7 million, changed N/A from the prior year.
- Operating Leases came in at $15.9 million for Q2 2026 at Mesa Laboratories, up from $13.7 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $15.9 million in Q2 2026 to a low of $13.7 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn |
| 10 | Mesa Laboratories | 684.72 Mn | 652.49 Mn | 39.01 Mn |